HEADER STRUCTURAL PROTEIN 30-JUL-07 2QS9 TITLE CRYSTAL STRUCTURE OF THE HUMAN RETINOBLASTOMA-BINDING TITLE 2 PROTEIN 9 (RBBP-9). NESG TARGET HR2978 COMPND MOL_ID: 1; COMPND 2 MOLECULE: RETINOBLASTOMA-BINDING PROTEIN 9; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: RBBP-9, RETINOBLASTOMA-BINDING PROTEIN 10, RBBP- COMPND 5 10, B5T OVEREXPRESSED GENE PROTEIN, BOG PROTEIN; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RBBP9, BOG, RBBP10; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)+MAGIC; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET21-23C KEYWDS RETINOBLASTOMA-BINDING PROTEIN 9, RETINOBLASTOMA-BINDING KEYWDS 2 PROTEIN 10, B5T OVEREXPRESSED GENE PROTEIN, BOG, RBBP9, KEYWDS 3 RBBP10, HR2978, NESG, STRUCTURAL GENOMICS, PSI-2, PROTEIN KEYWDS 4 STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS KEYWDS 5 CONSORTIUM, ALTERNATIVE SPLICING, CYTOPLASM, NUCLEUS, KEYWDS 6 PHOSPHORYLATION, STRUCTURAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR S.M.VOROBIEV,M.SU,J.SEETHARAMAN,A.KUZIN,C.X.CHEN, AUTHOR 2 K.CUNNINGHAM,L.OWENS,M.MAGLAQUI,R.XIAO,T.B.ACTON, AUTHOR 3 G.T.MONTELIONE,J.F.HUNT,L.TONG,NORTHEAST STRUCTURAL AUTHOR 4 GENOMICS CONSORTIUM (NESG) REVDAT 5 09-JUN-09 2QS9 1 REVDAT REVDAT 4 24-FEB-09 2QS9 1 VERSN REVDAT 3 23-DEC-08 2QS9 1 JRNL REVDAT 2 25-NOV-08 2QS9 1 JRNL REVDAT 1 14-AUG-07 2QS9 0 JRNL AUTH S.M.VOROBIEV,M.SU,J.SEETHARAMAN,Y.J.HUANG,C.X.CHEN, JRNL AUTH 2 M.MAGLAQUI,H.JANJUA,M.PROUDFOOT,A.YAKUNIN,R.XIAO, JRNL AUTH 3 T.B.ACTON,G.T.MONTELIONE,L.TONG JRNL TITL CRYSTAL STRUCTURE OF HUMAN RETINOBLASTOMA BINDING JRNL TITL 2 PROTEIN 9. JRNL REF PROTEINS V. 74 526 2008 JRNL REFN ISSN 0887-3585 JRNL PMID 19004028 JRNL DOI 10.1002/PROT.22278 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. 1.72 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.72 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.96 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 208046.590 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.5 REMARK 3 NUMBER OF REFLECTIONS : 67213 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.183 REMARK 3 FREE R VALUE : 0.203 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2691 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.72 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.83 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 9988 REMARK 3 BIN R VALUE (WORKING SET) : 0.2020 REMARK 3 BIN FREE R VALUE : 0.2330 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 422 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.011 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2963 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 414 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 11.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 12.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.40000 REMARK 3 B22 (A**2) : -0.34000 REMARK 3 B33 (A**2) : 0.74000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.88000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.17 REMARK 3 ESD FROM SIGMAA (A) : 0.05 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.08 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.30 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.85 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 58.57 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE FRIEDEL PAIRS WERE USED FOR REMARK 3 PHASING REMARK 4 REMARK 4 2QS9 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-AUG-07. REMARK 100 THE RCSB ID CODE IS RCSB043990. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-JUN-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X4A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97913 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 67796 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.720 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.04600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 25.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.72 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.78 REMARK 200 COMPLETENESS FOR SHELL (%) : 85.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : 0.08200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 14.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SHELX D/E, SOLVE, RESOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: THE STRUCTURE FACTOR FILE CONTAINS FRIEDEL PAIRS REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 35.43 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 40% PEG 4000, 0.1M MAGNESIUM REMARK 280 NITRATE, 0.1M SODIUM ACETATE PH 5.0, MICROBATCH UNDER OIL, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 65.17000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A 1 REMARK 465 ALA A 2 REMARK 465 MSE B 1 REMARK 465 ALA B 2 REMARK 465 LYS B 183 REMARK 465 VAL B 184 REMARK 465 PRO B 185 REMARK 465 ALA B 186 REMARK 465 LEU B 187 REMARK 465 GLU B 188 REMARK 465 HIS B 189 REMARK 465 HIS B 190 REMARK 465 HIS B 191 REMARK 465 HIS B 192 REMARK 465 HIS B 193 REMARK 465 HIS B 194 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 3 OG REMARK 470 LYS A 183 CG CD CE NZ REMARK 470 GLU A 188 CG CD OE1 OE2 REMARK 470 HIS A 194 CG ND1 CD2 CE1 NE2 REMARK 470 SER B 3 OG REMARK 470 ARG B 109 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 75 -111.44 56.08 REMARK 500 SER A 97 61.85 60.85 REMARK 500 PHE A 171 69.32 -158.67 REMARK 500 VAL A 184 73.11 55.28 REMARK 500 SER B 75 -111.98 57.22 REMARK 500 SER B 97 61.46 62.47 REMARK 500 LEU B 103 18.02 58.01 REMARK 500 PHE B 171 69.33 -155.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: HR2978 RELATED DB: TARGETDB DBREF 2QS9 A 1 186 UNP O75884 RBBP9_HUMAN 1 186 DBREF 2QS9 B 1 186 UNP O75884 RBBP9_HUMAN 1 186 SEQADV 2QS9 LEU A 187 UNP O75884 EXPRESSION TAG SEQADV 2QS9 GLU A 188 UNP O75884 EXPRESSION TAG SEQADV 2QS9 HIS A 189 UNP O75884 EXPRESSION TAG SEQADV 2QS9 HIS A 190 UNP O75884 EXPRESSION TAG SEQADV 2QS9 HIS A 191 UNP O75884 EXPRESSION TAG SEQADV 2QS9 HIS A 192 UNP O75884 EXPRESSION TAG SEQADV 2QS9 HIS A 193 UNP O75884 EXPRESSION TAG SEQADV 2QS9 HIS A 194 UNP O75884 EXPRESSION TAG SEQADV 2QS9 LEU B 187 UNP O75884 EXPRESSION TAG SEQADV 2QS9 GLU B 188 UNP O75884 EXPRESSION TAG SEQADV 2QS9 HIS B 189 UNP O75884 EXPRESSION TAG SEQADV 2QS9 HIS B 190 UNP O75884 EXPRESSION TAG SEQADV 2QS9 HIS B 191 UNP O75884 EXPRESSION TAG SEQADV 2QS9 HIS B 192 UNP O75884 EXPRESSION TAG SEQADV 2QS9 HIS B 193 UNP O75884 EXPRESSION TAG SEQADV 2QS9 HIS B 194 UNP O75884 EXPRESSION TAG SEQRES 1 A 194 MSE ALA SER PRO SER LYS ALA VAL ILE VAL PRO GLY ASN SEQRES 2 A 194 GLY GLY GLY ASP VAL THR THR HIS GLY TRP TYR GLY TRP SEQRES 3 A 194 VAL LYS LYS GLU LEU GLU LYS ILE PRO GLY PHE GLN CYS SEQRES 4 A 194 LEU ALA LYS ASN MSE PRO ASP PRO ILE THR ALA ARG GLU SEQRES 5 A 194 SER ILE TRP LEU PRO PHE MSE GLU THR GLU LEU HIS CYS SEQRES 6 A 194 ASP GLU LYS THR ILE ILE ILE GLY HIS SER SER GLY ALA SEQRES 7 A 194 ILE ALA ALA MSE ARG TYR ALA GLU THR HIS ARG VAL TYR SEQRES 8 A 194 ALA ILE VAL LEU VAL SER ALA TYR THR SER ASP LEU GLY SEQRES 9 A 194 ASP GLU ASN GLU ARG ALA SER GLY TYR PHE THR ARG PRO SEQRES 10 A 194 TRP GLN TRP GLU LYS ILE LYS ALA ASN CYS PRO TYR ILE SEQRES 11 A 194 VAL GLN PHE GLY SER THR ASP ASP PRO PHE LEU PRO TRP SEQRES 12 A 194 LYS GLU GLN GLN GLU VAL ALA ASP ARG LEU GLU THR LYS SEQRES 13 A 194 LEU HIS LYS PHE THR ASP CYS GLY HIS PHE GLN ASN THR SEQRES 14 A 194 GLU PHE HIS GLU LEU ILE THR VAL VAL LYS SER LEU LEU SEQRES 15 A 194 LYS VAL PRO ALA LEU GLU HIS HIS HIS HIS HIS HIS SEQRES 1 B 194 MSE ALA SER PRO SER LYS ALA VAL ILE VAL PRO GLY ASN SEQRES 2 B 194 GLY GLY GLY ASP VAL THR THR HIS GLY TRP TYR GLY TRP SEQRES 3 B 194 VAL LYS LYS GLU LEU GLU LYS ILE PRO GLY PHE GLN CYS SEQRES 4 B 194 LEU ALA LYS ASN MSE PRO ASP PRO ILE THR ALA ARG GLU SEQRES 5 B 194 SER ILE TRP LEU PRO PHE MSE GLU THR GLU LEU HIS CYS SEQRES 6 B 194 ASP GLU LYS THR ILE ILE ILE GLY HIS SER SER GLY ALA SEQRES 7 B 194 ILE ALA ALA MSE ARG TYR ALA GLU THR HIS ARG VAL TYR SEQRES 8 B 194 ALA ILE VAL LEU VAL SER ALA TYR THR SER ASP LEU GLY SEQRES 9 B 194 ASP GLU ASN GLU ARG ALA SER GLY TYR PHE THR ARG PRO SEQRES 10 B 194 TRP GLN TRP GLU LYS ILE LYS ALA ASN CYS PRO TYR ILE SEQRES 11 B 194 VAL GLN PHE GLY SER THR ASP ASP PRO PHE LEU PRO TRP SEQRES 12 B 194 LYS GLU GLN GLN GLU VAL ALA ASP ARG LEU GLU THR LYS SEQRES 13 B 194 LEU HIS LYS PHE THR ASP CYS GLY HIS PHE GLN ASN THR SEQRES 14 B 194 GLU PHE HIS GLU LEU ILE THR VAL VAL LYS SER LEU LEU SEQRES 15 B 194 LYS VAL PRO ALA LEU GLU HIS HIS HIS HIS HIS HIS MODRES 2QS9 MSE A 44 MET SELENOMETHIONINE MODRES 2QS9 MSE A 59 MET SELENOMETHIONINE MODRES 2QS9 MSE A 82 MET SELENOMETHIONINE MODRES 2QS9 MSE B 44 MET SELENOMETHIONINE MODRES 2QS9 MSE B 59 MET SELENOMETHIONINE MODRES 2QS9 MSE B 82 MET SELENOMETHIONINE HET MSE A 44 8 HET MSE A 59 8 HET MSE A 82 8 HET MSE B 44 8 HET MSE B 59 8 HET MSE B 82 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 6(C5 H11 N O2 SE) FORMUL 3 HOH *414(H2 O) HELIX 1 1 TRP A 23 GLU A 32 1 10 HELIX 2 2 ARG A 51 GLU A 62 1 12 HELIX 3 3 SER A 75 HIS A 88 1 14 HELIX 4 4 ASP A 105 SER A 111 1 7 HELIX 5 5 GLN A 119 CYS A 127 1 9 HELIX 6 6 PRO A 142 GLU A 154 1 13 HELIX 7 7 PHE A 171 LYS A 183 1 13 HELIX 8 8 TRP B 23 GLU B 32 1 10 HELIX 9 9 ARG B 51 GLU B 62 1 12 HELIX 10 10 SER B 75 ALA B 85 1 11 HELIX 11 11 ASP B 105 SER B 111 1 7 HELIX 12 12 GLN B 119 CYS B 127 1 9 HELIX 13 13 PRO B 142 GLU B 154 1 13 HELIX 14 14 PHE B 171 LEU B 182 1 12 SHEET 1 A 6 CYS A 39 ALA A 41 0 SHEET 2 A 6 LYS A 6 VAL A 10 1 N ILE A 9 O LEU A 40 SHEET 3 A 6 THR A 69 HIS A 74 1 O ILE A 72 N VAL A 8 SHEET 4 A 6 ALA A 92 VAL A 96 1 O VAL A 94 N ILE A 71 SHEET 5 A 6 TYR A 129 SER A 135 1 O PHE A 133 N LEU A 95 SHEET 6 A 6 LYS A 156 PHE A 160 1 O HIS A 158 N GLN A 132 SHEET 1 B 6 GLN B 38 LEU B 40 0 SHEET 2 B 6 LYS B 6 VAL B 10 1 N ILE B 9 O LEU B 40 SHEET 3 B 6 THR B 69 HIS B 74 1 O ILE B 72 N VAL B 8 SHEET 4 B 6 ALA B 92 VAL B 96 1 O VAL B 94 N ILE B 71 SHEET 5 B 6 TYR B 129 SER B 135 1 O PHE B 133 N LEU B 95 SHEET 6 B 6 LYS B 156 PHE B 160 1 O HIS B 158 N GLN B 132 LINK C ASN A 43 N MSE A 44 1555 1555 1.33 LINK C MSE A 44 N PRO A 45 1555 1555 1.34 LINK C PHE A 58 N MSE A 59 1555 1555 1.33 LINK C MSE A 59 N GLU A 60 1555 1555 1.33 LINK C ALA A 81 N MSE A 82 1555 1555 1.33 LINK C MSE A 82 N ARG A 83 1555 1555 1.33 LINK C ASN B 43 N MSE B 44 1555 1555 1.33 LINK C MSE B 44 N PRO B 45 1555 1555 1.35 LINK C PHE B 58 N MSE B 59 1555 1555 1.33 LINK C MSE B 59 N GLU B 60 1555 1555 1.33 LINK C ALA B 81 N MSE B 82 1555 1555 1.33 LINK C MSE B 82 N ARG B 83 1555 1555 1.33 CRYST1 37.081 130.340 39.047 90.00 115.87 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026968 0.000000 0.013075 0.00000 SCALE2 0.000000 0.007672 0.000000 0.00000 SCALE3 0.000000 0.000000 0.028462 0.00000